MYX 5.80% $6.66 mayne pharma group limited

Ann: Chairman and CEO's Addresses to Shareholders, page-4

  1. 754 Posts.
    lightbulb Created with Sketch. 125
    noticed that narrative has changed now - it used to be nuvaring nuvaring...

    this will fade into the abyss i think as they haven't even addressed the additional FDA requirements and once that has been submitted, this will take at least half a year for an action date. by then it will be an irrelevant product as the first to launch has gained traction and there might be more generic similar products already approved.

    same narrative though in their excuses of getting lower sales due to competition. ALTHOUGH i note that specialty division which was once touted as the future of the firm is already facing problems in competitive products.

    scott should go... even charts can probably do a better job than scott!
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$6.66
Change
-0.410(5.80%)
Mkt cap ! $566.5M
Open High Low Value Volume
$7.03 $7.03 $6.28 $4.982M 759.0K

Buyers (Bids)

No. Vol. Price($)
1 231 $6.66
 

Sellers (Offers)

Price($) Vol. No.
$6.67 158 1
View Market Depth
Last trade - 16.10pm 14/05/2024 (20 minute delay) ?
Last
$6.62
  Change
-0.410 ( 6.31 %)
Open High Low Volume
$6.99 $7.00 $6.29 115373
Last updated 15.59pm 14/05/2024 ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.